Literature DB >> 33414779

Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis.

Sepehr Aghajanian1, Majid Teymoori-Rad2, Ghazale Molaverdi1, Sayed-Hamidreza Mozhgani3,4.   

Abstract

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is a neuropathological disorder in 1-3% of individuals infected with Human T-lymphotropic virus 1 (HTLV-1). This condition is characterized by progressive spastic lower limb weakness and paralysis, lower back pain, bladder incontinence, and mild sensory disturbances resembling spinal forms of multiple sclerosis. This disease also causes chronic disability and is therefore associated with high health burden in areas where HTLV-1 infection is endemic. Despite various efforts in understanding the virus and discovery of novel diagnostic markers, and cellular and viral interactions, HAM/TSP management is still unsatisfactory and mainly focused on symptomatic alleviation, and it hasn't been explained why only a minority of the virus carriers develop HAM/TSP. This comprehensive review focuses on host and viral factors in association with immunopathology of the disease in hope of providing new insights for drug therapies or other forms of intervention.
Copyright © 2020 Aghajanian, Teymoori-Rad, Molaverdi and Mozhgani.

Entities:  

Keywords:  HAM/TSP; HTLV-1-associated myelopathy; human T-lymphotropic virus; immunology; pathogenesis

Year:  2020        PMID: 33414779      PMCID: PMC7783048          DOI: 10.3389/fmicb.2020.614940

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  240 in total

1.  Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation.

Authors:  H A Giebler; J E Loring; K van Orden; M A Colgin; J E Garrus; K W Escudero; A Brauweiler; J K Nyborg
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.

Authors:  F Umehara; Y Okada; N Fujimoto; M Abe; S Izumo; M Osame
Journal:  J Neuropathol Exp Neurol       Date:  1998-09       Impact factor: 3.685

3.  Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.

Authors:  Saifur Rahman; Sharrón L Manuel; Zafar K Khan; Brian Wigdahl; Edward Acheampong; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

4.  Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system.

Authors:  I A Romero; M C Prevost; E Perret; P Adamson; J Greenwood; P O Couraud; S Ozden
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  An inverse correlation of HTLV-I viral load in CSF and intrathecal synthesis of HTLV-I antibodies in TSP/HAM.

Authors:  M Puccioni-Sohler; M Rios; C Bianco; S W Zhu; C Oliveira; S A Novis; M S Pombo-de-Oliveira
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

Review 6.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

7.  Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Ying K Huang; Daniel C Bertolette; Francis W Ruscetti
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

Review 8.  HTLV-1 Associated Neurological Complex. What is Hidden below the Water?

Authors:  Abelardo Q C Araujo; Diego Wedemann
Journal:  AIDS Rev       Date:  2019       Impact factor: 2.500

Review 9.  Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.

Authors:  Natsumi Araya; Tomoo Sato; Naoko Yagishita; Hitoshi Ando; Atae Utsunomiya; Steven Jacobson; Yoshihisa Yamano
Journal:  Viruses       Date:  2011-08-25       Impact factor: 5.048

10.  Induction of OX40, a receptor of gp34, on T cells by trans-acting transcriptional activator, Tax, of human T-cell leukemia virus type I.

Authors:  N Higashimura; N Takasawa; Y Tanaka; M Nakamura; K Sugamura
Journal:  Jpn J Cancer Res       Date:  1996-03
View more
  1 in total

1.  Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK/JNK signal transduction pathway in Adult T-cell leukemia/lymphoma.

Authors:  Shahrzad Shadabi; Nargess Delrish; Mehdi Norouzi; Maryam Ehteshami; Fariba Habibian-Sezavar; Samira Pourrezaei; Mobina Madihi; Mohammadreza Ostadali; Foruhar Akhgar; Ali Shayeghpour; Cobra Razavi Pashabayg; Sepehr Aghajanian; Sayed-Hamidreza Mozhgani; Seyed-Mohammad Jazayeri
Journal:  Infect Agent Cancer       Date:  2021-06-29       Impact factor: 2.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.